Koyfin Home > Directory > Health Care > Antares Pharma > Return on Assets %

Antares Pharma Return on Assets % Chart (ATRS)

Antares Pharma annual/quarterly Return on Assets % from 2001 to 2018.
  • Antares Pharma Return on Assets % for the quarter ending December 12, 2018 was -17.54 a -9.89% increase of 1.73 year over year
  • Antares Pharma Return on Assets % for the last 12 months ending December 12, 2018 was -12.76 a -26.71% increase of 3.41 year over year
  • Antares Pharma Annual Return on Assets % for 2018 was -12.76 a -14.56% increase of 1.86 from 2017
  • Antares Pharma Annual Return on Assets % for 2017 was -14.62 a -36.67% increase of 5.36 from 2016
  • Antares Pharma Annual Return on Assets % for 2016 was -19.98 a 16.51% decrease of -3.30 from 2015
Other Margins & Efficiency Metrics:
  • Antares Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-27m a -45.38% increase of 12m year over year
  • Antares Pharma Return on Capital % for the quarter ending December 12, 2018 was -25.15 a -0.12% increase of 0.03 year over year
  • Antares Pharma Return on Equity % for the quarter ending December 12, 2018 was 77.43 a 203.55% increase of 157.61 year over year
View Chart On Koyfin

Quarterly ATRS Return on Assets % Data

12/2018-17.54
09/2018-4.58
06/2018-13.46
03/2018-19.27
12/2017-13.15
09/2017-15.28
06/2017-9.34
03/2017-18.52
12/2016-15.39
09/2016-20.35

Annual ATRS Return on Assets % Data

2018-12.76
2017-14.62
2016-19.98
2015-16.68
2014-27.83
2013-14.13
2012-10.41
2011-9.71
2010-21.97
2009-31.03